INTELIVATION TECHNOLOGIES ANNOUNCES COMMERCIAL LAUNCH OF HAMMERDESIS™
Hammerdesis™ allows surgeons to correct inter phalangeal deformities such as hammertoes by simply affixing a distinctively designed ring on the patient's toe joint. This one-of-a-kind implant benefits both surgeons and patients by saving surgeons significant intraoperative time and yielding cost savings in the Ambulatory Surgery Center setting.
Jason R. Miller DPM FACFAS of Premier Orthopedics remarked, "I am looking forward to the launch of the Hammerdesis™ System. This will not only bring time savings in the OR, but also provide optimal fusion of the joint. The peg and hole procedure has been clinically proven to be very effective, and the Hammerdesis™ is the ideal implant for this procedure."
Founder & CEO
"Our sales team and launch site surgeons are thrilled to be a part of the Hammerdesis Launch. The ability to provide such a significant result by simply 'putting a ring on it' is a game-changer for channel partners, surgeons, and patients alike." added VP of Sales and GM,
Intelivation Technologies is exhibiting at the annual ACFAS Conference
About Intelivation Technologies
Intelivation Technologies, dedicated to research and development, is focused on bringing paradigm-changing products to market that make patients' lives better. For further inquiries, interested parties may email [email protected].
View original content to download multimedia:https://www.prnewswire.com/news-releases/intelivation-technologies-announces-commercial-launch-of-hammerdesis-302050663.html
SOURCE Intelivation Technologies
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- European Approval for Production Organisation Dutch Flying Car Company PAL-V
- Digital Realty Strengthens Nairobi as East Africa Digital Gateway with New Data Center
- Form 8.5 (EPT/RI)-Advanced Medical Solutions Group Plc
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share